Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Impact of Coenzyme Q10 and Meclofenoxate on Frequency and Severity of Hepatic Encephalopathy

NCT03961087 is registered in ClinicalTrials.gov with Zagazig University as lead sponsor.

Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03961087 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Impact of Coenzyme Q10 and Meclofenoxate on Frequency and Severity of Hepatic Encephalopathy
Lead sponsor
Zagazig University
Phase
Not applicable
Overall status
Unknown status
Start date
May 23, 2019
Completion date
February 1, 2020
Enrollment
300 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

coenzyme q10, hepatic encephalopathy, intellectual functioning disability